Philippines officials nix Sanofi's appeal on Dengvaxia ban by Eric Sagonowsky Thursday, August 22, 2019 Sanofi lost an appeal challenging the ban on its dengue vaccine Dengvaxia in the Philippines, despite an ongoing outbreak there.
Sanofi's Dengvaxia back on the table in the Philippines by Eric Sagonowsky Monday, August 5, 2019 After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.
Sartan recall, China high-tech board and more—FiercePharmaAsia by Angus Liu Friday, March 8, 2019 A third carcinogen was found in sartan drugs; China unveiled final rules for a Nasdaq-style board; Philippines preps to indict Sanofi officials.
Philippine DOJ to charge Sanofi officials in Dengvaxia disaster by Eric Sagonowsky Friday, March 1, 2019 Prosecutors in the Philippines have found probable cause to indict six Sanofi officials for its Dengvaxia rollout.
Families with alleged Dengvaxia deaths target Sanofi execs by Angus Liu Tuesday, April 10, 2018 New legal complaints focus on eight Sanofi executives, most of them with local management titles, and 15 managers at distributor Zuellig Pharma.
Sanofi denies Dengvaxia refund request; Philippines preps suit by Eric Sagonowsky Wednesday, February 21, 2018 After two refusals from Sanofi to provide a refund for the Dengvaxia program, officials in the Philippines say they are getting ready to sue.
Sanofi refuses to refund Philippines for used Dengvaxia by Angus Liu Monday, February 5, 2018 “Agreeing to refund the used doses of Dengvaxia would imply that the vaccine is ineffective, which is not the case,” said Sanofi.
Philippine DOH demands full Dengvaxia refund from Sanofi by Angus Liu Tuesday, January 30, 2018 The Philippine DOH is now officially asking Sanofi to refund some $39 million for used Dengvaxia doses as well.
Sanofi to pay for proven Dengvaxia adverse events in Philippines by Eric Sagonowsky Tuesday, January 23, 2018 A Sanofi executive said the company will "shoulder the cost" of any adverse events that are scientifically linked to vaccination.
Sanofi to refund Philippines $28M for unused Dengvaxia doses by Angus Liu Tuesday, January 16, 2018 As investigations in the Philippines proceed, Sanofi Pasteur has agreed to refund the cost of unused Dengvaxia doses worth about $28 million.
